U.S. Animal Vaccines Market Size, Share & Trends Analysis Report By Product, By Animal Type (Livestock, Companion), By Route Of Administration (Subcutaneous, Intramuscular), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Product
                       1.2.2. Animal Type
                       1.2.3. Route of Administration
                       1.2.4. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product Outlook
                       2.2.2. Animal Type Outlook
                       2.2.3. Route of Administration Outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Animal Vaccines Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                       3.2.2. Market restraint analysis
                       3.2.3. Market opportunity analysis
                   3.3. U.S. Animal Vaccines Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. U.S. Animal Vaccines Market: Product Estimates & Trend Analysis
                   4.1. U.S. Animal Vaccines Market: Product Dashboard
                   4.2. U.S. Animal Vaccines Market: Product Movement Analysis
                   4.3. U.S. Animal Vaccines Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   4.4. Attenuated Live Vaccines
                       4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.5. Inactivated Vaccines
                       4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.6. Subunit Vaccines
                       4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.7. DNA Vaccines
                       4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.8. Recombinant Vaccines
                       4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Animal Vaccines Market: Animal Type Estimates & Trend Analysis
                   5.1. U.S. Animal Vaccines Market: Animal Type Dashboard
                   5.2. U.S. Animal Vaccines Market: Animal Type Movement Analysis
                   5.3. U.S. Animal Vaccines Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   5.4. Livestock
                       5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.2. Poultry
                           5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.3. Aqua
                           5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.4. Ruminants
                           5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.5. Swine
                           5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.5. Companion
                       5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.5.2. Canine
                           5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.5.3. Feline
                           5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.5.4. Others
                           5.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Animal Vaccines Market: Route of Administration Estimates & Trend Analysis
                   6.1. U.S. Animal Vaccines Market: Route of Administration Dashboard
                   6.2. U.S. Animal Vaccines Market: Route of Administration Analysis
                   6.3. U.S. Animal Vaccines Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   6.4. Subcutaneous
                       6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.5. Intramuscular
                       6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.6. Intranasal
                       6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                   7.3. Vendor Landscape
                       7.3.1. List of key distributors and channel partners
                       7.3.2. Key customers
                       7.3.3. Key company market share analysis, 2023
                       7.3.4. Zoetis
                           7.3.4.1. Company overview
                           7.3.4.2. Financial performance
                           7.3.4.3. Product benchmarking
                           7.3.4.4. Strategic initiatives
                       7.3.5. Ceva Santé Animale
                           7.3.5.1. Company overview
                           7.3.5.2. Financial performance
                           7.3.5.3. Product benchmarking
                           7.3.5.4. Strategic initiatives
                       7.3.6. Merck & Co., Inc.
                           7.3.6.1. Company overview
                           7.3.6.2. Financial performance
                           7.3.6.3. Product benchmarking
                           7.3.6.4. Strategic initiatives
                       7.3.7. Vetoquinol S.A.
                           7.3.7.1. Company overview
                           7.3.7.2. Financial performance
                           7.3.7.3. Product benchmarking
                           7.3.7.4. Strategic initiatives
                       7.3.8. Boehringer Ingelheim Gmbh
                           7.3.8.1. Company overview
                           7.3.8.2. Financial performance
                           7.3.8.3. Product benchmarking
                           7.3.8.4. Strategic initiatives
                       7.3.9. Elanco
                           7.3.9.1. Company overview
                           7.3.9.2. Financial performance
                           7.3.9.3. Product benchmarking
                           7.3.9.4. Strategic initiatives
                       7.3.10. Virbac
                           7.3.10.1. Company overview
                           7.3.10.2. Financial performance
                           7.3.10.3. Product benchmarking
                           7.3.10.4. Strategic initiatives
                       7.3.11. Heska
                           7.3.11.1. Company overview
                           7.3.11.2. Financial performance
                           7.3.11.3. Product benchmarking
                           7.3.11.4. Strategic initiatives
                       7.3.12. Dechra Pharmaceuticals Plc
                           7.3.12.1. Company overview
                           7.3.12.2. Financial performance
                           7.3.12.3. Product benchmarking
                           7.3.12.4. Strategic initiatives
                       7.3.13. Idexx Laboratories, Inc.
                           7.3.13.1. Company overview
                           7.3.13.2. Financial performance
                           7.3.13.3. Product benchmarking
                           7.3.13.4. Strategic initiatives
                       7.3.14. Norbrook Inc.
                           7.3.14.1. Company overview
                           7.3.14.2. Financial performance
                           7.3.14.3. Product benchmarking
                           7.3.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 US animal vaccines market, 2018 - 2030 (USD Million)
Table 3 US animal vaccines market, by product, 2018 - 2030 (USD Million)
Table 4 US animal vaccines market, by animal type, 2018 - 2030 (USD Million)
Table 5 US animal vaccines market, by route of administration, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. animal vaccines market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. animal vaccines market: Product outlook and key takeaways
Fig. 16 U.S. animal vaccines market: Product movement analysis
Fig. 17 Attenuated live vaccines market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Inactivated vaccines market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Subunit vaccines market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 DNA vaccines market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Recombinant vaccines market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 U.S. animal vaccines market: Animal type outlook and key takeaways
Fig. 23 U.S. animal vaccines market: Animal type movement analysis
Fig. 24 Livestock market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Companion market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 U.S. animal vaccines market: Route of administration outlook and key takeaways
Fig. 27 U.S. animal vaccines market: Route of administration movement analysis
Fig. 28 Subcutaneous market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Intramuscular market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Intranasal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Company market share analysis, 2023
Fig. 32 Strategic framework